In a report released today, Anthony Vendetti from Maxim Group maintained a Hold rating on Applied DNA Sciences (APDN). The company’s shares opened today at $0.83.
Vendetti commented:
“On March 29, 2019, APDN announced an exclusive supply chain licensing agreement with TheraCann (private), a cannabis and hemp consultancy.”
According to TipRanks.com, Vendetti is a 4-star analyst with an average return of 6.1% and a 52.6% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Ellex Medical Lasers Limited, Restoration Robotics Inc, and Ra Medical Systems Inc.
The the analyst consensus on Applied DNA Sciences is currently a Hold rating.
See today’s analyst top recommended stocks >>
Based on Applied DNA Sciences’ latest earnings release for the quarter ending December 31, the company reported a quarterly GAAP net loss of $3.23 million. In comparison, last year the company had a GAAP net loss of $3.18 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion.
